Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8284)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 9, 2025 (publication date) through Nov 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Samanta A, Srivastava A. Biologics in the management of pediatric inflammatory bowel disease: When and what to choose. World J Clin Pediatr 2025; 14(1): 100938 [PMID: 40059900 DOI: 10.5409/wjcp.v14.i1.100938] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Samanta A, Srivastava A. Biologics in the management of pediatric inflammatory bowel disease: When and what to choose. World J Clin Pediatr 2025; 14(1): 100938 [PMID: 40059900 DOI: 10.5409/wjcp.v14.i1.100938] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2808/full/v14/i1/100938.htm |
| Number | Citing Articles |
| 1 |
Serena Yun‐Chen Tsai, Ashwin N. Ananthakrishnan, Harland S. Winter, Kevin Sheng‐Kai Ma. Comparative risk of serious infection among biologic therapies for inflammatory bowel disease in pediatric patients: A target trial emulation. Journal of Pediatric Gastroenterology and Nutrition 2025; doi: 10.1002/jpn3.70251
|